Aperio Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $34.6M | Buy |
210,467
+15,151
| +8% | +$2.22M | 0.1% | 196 |
|
|
2020
Q3 | $24.4M | Buy |
195,316
+21,256
| +12% | +$2.63M | 0.08% | 231 |
|
|
2020
Q2 | $16.9M | Sell |
174,060
-66,287
| -28% | -$6.89M | 0.06% | 300 |
|
|
2020
Q1 | $21.6M | Sell |
240,347
-7,207
| -3% | -$933K | 0.1% | 216 |
|
|
2019
Q4 | $36.6M | Sell |
247,554
-6,519
| -3% | -$875K | 0.13% | 172 |
|
|
2019
Q3 | $30.6M | Sell |
254,073
-3,237
| -1% | -$418K | 0.12% | 195 |
|
|
2019
Q2 | $34.8M | Sell |
257,310
-6,806
| -3% | -$861K | 0.14% | 156 |
|
|
2019
Q1 | $34.4M | Buy |
264,116
+20,700
| +9% | +$2.78M | 0.15% | 149 |
|
|
2018
Q4 | $30.3M | Buy |
243,416
+18,802
| +8% | +$2.52M | 0.15% | 145 |
|
|
2018
Q3 | $31.2M | Buy |
224,614
+15,680
| +8% | +$1.95M | 0.14% | 164 |
|
|
2018
Q2 | $21.4M | Buy |
208,934
+26,479
| +15% | +$2.68M | 0.1% | 222 |
|
|
2018
Q1 | $17.7M | Buy |
182,455
+12,491
| +7% | +$1.21M | 0.09% | 266 |
|
|
2017
Q4 | $14.9M | Sell |
169,964
-24,482
| -13% | -$1.97M | 0.08% | 306 |
|
|
2017
Q3 | $15.5M | Sell |
194,446
-6,357
| -3% | -$511K | 0.09% | 275 |
|
|
2017
Q2 | $17.5M | Buy |
200,803
+14,456
| +8% | +$1.22M | 0.11% | 219 |
|
|
2017
Q1 | $16.6M | Buy |
186,347
+33,039
| +22% | +$2.75M | 0.11% | 213 |
|
|
2016
Q4 | $11.3M | Buy |
153,308
+3,952
| +3% | +$296K | 0.09% | 270 |
|
|
2016
Q3 | $11.3M | Buy |
149,356
+3,881
| +3% | +$297K | 0.08% | 287 |
|
|
2016
Q2 | $11.2M | Buy |
145,475
+15,823
| +12% | +$1.25M | 0.09% | 268 |
|
|
2016
Q1 | $10.1M | Buy |
129,652
+48,725
| +60% | +$3.4M | 0.09% | 270 |
|
|
2015
Q4 | $5.47M | Sell |
80,927
-4,501
| -5% | -$314K | 0.05% | 433 |
|
|
2015
Q3 | $6.61M | Buy |
85,428
+11,486
| +16% | +$1.02M | 0.07% | 349 |
|
|
2015
Q2 | $6.71M | Buy |
73,942
+12,153
| +20% | +$974K | 0.07% | 327 |
|
|
2015
Q1 | $4.65M | Buy |
61,789
+10,714
| +21% | +$769K | 0.05% | 429 |
|
|
2014
Q4 | $3.75M | Buy |
51,075
+4,071
| +9% | +$286K | 0.05% | 462 |
|
|
2014
Q3 | $3.32M | Buy |
47,004
+8,972
| +24% | +$593K | 0.04% | 469 |
|
|
2014
Q2 | $2.14M | Buy |
38,032
+2,288
| +6% | +$121K | 0.03% | 573 |
|
|
2014
Q1 | $1.88M | Buy |
+35,744
| New | +$1.78M | 0.03% | 720 |
|
|
2013
Q4 | – | Sell |
-25,753
| Closed | -$1.19M | – | 768 |
|
|
2013
Q3 | $1.1M | Buy |
25,753
+1,195
| +5% | +$46.7K | 0.02% | 810 |
|
|
2013
Q2 | $886K | Buy |
+24,558
| New | +$950K | 0.02% | 808 |
|
Other funds holding HCA
Aperio Group's HCA Position: Q4 2020 in Review
Aperio Group increased its HCA Healthcare (HCA) stake by 7.8% in Q4 2020, buying an estimated $2.22M and bringing the position to 210,467 shares worth $34.6M. The position accounts for 0.1% of the portfolio, ranked #196.
Aperio Group first reported a position in HCA in Q2 2013 and has held it in 30 quarters since. The position peaked at $36.6M in Q4 2019. 779 funds tracked by Wall St. Rank hold HCA as of Q4 2020.
- Aperio Group held 210,467 shares of HCA Healthcare worth $34.6M as of Q4 2020.
- Aperio Group bought 15,151 HCA Healthcare shares in Q4 2020, an estimated $2.22M.
- HCA Healthcare made up 0.1% of Aperio Group's portfolio in Q4 2020, its #196 holding.
- Aperio Group first reported a position in HCA Healthcare in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's HCA Healthcare position peaked at $36.6M in Q4 2019.
- 779 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.